Building AI Champions: A Scalable Model for Life Sciences Teams

CHALLENGE A 20-member field force  spread across six states faced mounting pressure to sharpen their medication’s competitive positioning, speed prior authorizations to ensure patient access, and maximize time spent on high-value HCP relationships rather than administrative tasks – all while maintaining excellence across multiple portfolios. Despite strong technical comfort levels, only 59–64% of the team […]

Achieving Launch Success: 100% of Marketing Assets Approved and Ready on Day One

CHALLENGE A global pharmaceutical company was preparing to launch a new drug and needed additional brand marketing support. Managing multiple digital and print marketing materials across various vendors required precise coordination to ensure timely approval and submission to the FDA. The Brand team needed a dedicated resource to oversee third-party agencies and internal workstreams, guaranteeing […]

Driving Strategic Program Execution for a $14B Global Pharmaceutical Product

CHALLENGE  A leading pharmaceutical company’s Development Program Management Team (DPM) was responsible for executing the strategic direction of programs from preclinical through commercialization. This included implementing the Integrated Development Plan (IDP), which encompassed goals, budgets, timelines, and governance touchpoints. With an expanding pipeline for a $14 billion global product, the department faced resource constraints and […]

Elevating Performance: Integrating Project Management into Data Analytics Operations

CHALLENGE  A leading life sciences data analytics team was facing mounting challenges in managing competing internal priorities. Operating in a “rapid response” environment, the team frequently encountered scope creep, unmet client expectations, and increasing burnout. Without a strong project management foundation, they struggled to balance responsiveness with the structure needed to deliver consistent, high-quality results.  […]

Enabling On-Time Vaccine Delivery Through Global Alignment

CHALLENGE A large, global pharmaceutical company required a CMK Select Project Manager to lead a key initiative for their global vaccine program. The team faced multiple operational barriers across 10+ countries and 5 continents, including time zone differences, language barriers, lack of cohesive governance, ineffective communication practices, unreadable lab reports in multiple languages, inconsistent lab […]

Ensuring a Successful Oncology Launch Through GPO Email Readiness

CHALLENGE A large pharmaceutical company preparing to launch a new cancer therapy faced a critical regulatory challenge. The company’s advertising agency, while experienced in promotional materials, lacked the specialized knowledge required to prepare Group Purchasing Organization (GPO) emails – a key component of the launch communication strategy. These emails must be submitted to the FDA […]

Focused Efficiency and Compliance Under Pressure: Managing Multiple Promotional Safety Label Updates in Nine Months

CHALLENGE A major pharmaceutical company’s oncology brand faced an unexpected challenge – three critical product label updates required within a nine-month period, all without additional funding. The accelerated timeline, combined with the need to maintain full regulatory and compliance alignment, placed intense pressure on internal teams and resources. Without careful coordination, the risk of missed […]

From Planning to Launch: Achieving Readiness in Under 12 Months

CHALLENGE A leading global pharmaceutical company aimed to launch a key oncology asset in the U.S. through a strategic licensing agreement. With an aggressive timeline of less than 12 months, the company needed seamless coordination across multiple functions, including Regulatory & Labeling, Manufacturing, Market Analytics, Access & Reimbursement, and Medical Affairs. Ensuring alignment among all […]

Accelerating Oncology Launch: How CMK Select Reduced Delays by 60%

CHALLENGE A leading pharmaceutical company was developing an oncology compound that received FDA Breakthrough Therapy designation, granting expedited approval. With this designation, the company faced a critical challenge: ensuring adequate drug supply at launch to meet urgent patient needs and capitalize on early revenue opportunities. However, the existing timeline projected a two-month delay in product […]